Announced Fri, 26 Jun · 16:52 IST
Trading Window Closure Ahead of Q1 FY27 Results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+8.3%1-day move
₹36.00
prior close
₹36.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0———+8.3+3.0+0.6-2.8-2.1-7.3-11.4———
Up moveDown movePending
AI summary
Pharmaids Pharmaceuticals has informed BSE that the trading window for designated persons and their immediate relatives will remain closed from July 01, 2026 until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. This is a routine SEBI Insider Trading Regulation compliance filing. The board meeting date to consider Q1 results will be announced separately.
Likely market impact
Routine compliance filing. No direct impact on retail shareholders. Signals upcoming Q1 FY27 results announcement.